{"doi":"10.1157/13083372","title":"¿Cuánta primaquina es necesaria para erradicar los hipnozoitos de Plasmodium vivax?","abstract":null,"journal":"Enfermedades Infecciosas y Microbiología Clínica","year":2006,"id":22310,"datarank":0.4420815798114901,"base_score":1.791759469228055,"endowment":1.791759469228055,"self_citation_contribution":0.26876392038420827,"citation_network_contribution":0.17331765942728186,"self_endowment_contribution":0.26876392038420827,"citer_contribution":0.17331765942728186,"corpus_percentile":null,"corpus_rank":null,"citation_count":5,"citer_count":2,"citers_with_citation_signal":2,"citers_with_endowment":2,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":140682,"name":"María Velasco","orcid":null,"position":1,"is_corresponding":false},{"id":140683,"name":"David Alonso","orcid":null,"position":2,"is_corresponding":false},{"id":140684,"name":"María Eugenia Valls","orcid":null,"position":3,"is_corresponding":false},{"id":140685,"name":"Manuel Corachán","orcid":null,"position":4,"is_corresponding":false},{"id":140686,"name":"Joaquim Gascón","orcid":null,"position":5,"is_corresponding":false},{"id":140681,"name":"José Muñoz","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":1.791759469228055,"endowment":1.791759469228055,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"16537060","pmcid":null,"openalex_id":"https://openalex.org/W2133323709","authors":[],"funders":[],"total_grants":0,"fwci":1.2984,"citation_percentile":0.828921,"influential_citations":0,"citation_trend":[{"year":2014,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0213005X06737168?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0213005X06737168?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1157/13083372","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/16537060","host_type":"repository"}],"fields_of_study":["Malaria Research and Control","Neonatal Health and Biochemistry","Hemoglobinopathies and Related Disorders","Medicine","Adult","Animals","Antimalarials","Drug Tolerance","Humans","Malaria, Vivax","Middle Aged","Plasmodium vivax","Primaquine"],"mesh_terms":["Adult","Animals","Antimalarials","Drug Tolerance","Humans","Middle Aged","Plasmodium vivax","Primaquine","Malaria, Vivax"],"keywords":["Primaquine","Plasmodium vivax","Malaria","Vivax malaria","Drug","Medicine","Biology","Pharmacology","Immunology","Virology","Plasmodium falciparum","Chloroquine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-06T18:49:53.630876Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}